Publications
Selected publications
- <i>Acinetobacter baumannii</i> transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-<i>Acinetobacter</i> drug development and AMR preparedness. (Journal article - 2024)
- Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>. (Journal article - 2024)
- Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced <i>Acinetobacter baumannii</i> persisters. (Journal article - 2023)
- Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections. (Journal article - 2022)
- The unusual glycine-rich C terminus of the <i>Acinetobacter baumannii</i> RNA chaperone Hfq plays an important role in bacterial physiology. (Journal article - 2018)
2025
Author Correction: Combining antibiotics to tackle antimicrobial resistance.
Hope, W., Nambiar, S., O'Brien, S., Sharland, M., Paterson, D. L., Yin, M., . . . Pre-X Investigators. (2025). Author Correction: Combining antibiotics to tackle antimicrobial resistance.. Nature microbiology. doi:10.1038/s41564-025-02003-w
Combining antibiotics to tackle antimicrobial resistance.
Hope, W., Nambiar, S., O'Brien, S., Sharland, M., Paterson, D. L., Yin, M., . . . Pre-X Investigators. (2025). Combining antibiotics to tackle antimicrobial resistance.. Nature microbiology, 10(4), 813-816. doi:10.1038/s41564-025-01969-x
Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation.
Darlow, C. A., Hope, W., & Dubey, V. (2025). Cefepime/Enmetazobactam: a microbiological, pharmacokinetic, pharmacodynamic, and clinical evaluation.. Expert opinion on drug metabolism & toxicology, 21(2), 115-123. doi:10.1080/17425255.2024.2427310
2024
Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef.
Owen, V., Harper, N., Dubey, V., Gerada, A., Boyd, S. E., & Darlow, C. A. (2024). Susceptibility of OXA-48-like-producing Enterobacterales to flomoxef.. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 30(12), 1606-1608. doi:10.1016/j.cmi.2024.07.017
<i>Acinetobacter baumannii</i> transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-<i>Acinetobacter</i> drug development and AMR preparedness.
Dubey, V., Farrington, N., Harper, N., Johnson, A., Horner, I., Stevenson, A., . . . Hope, W. (2024). <i>Acinetobacter baumannii</i> transformants expressing oxacillinases and metallo-β-lactamases that confer resistance to meropenem: new tools for anti-<i>Acinetobacter</i> drug development and AMR preparedness.. Antimicrobial agents and chemotherapy, 68(10), e0022224. doi:10.1128/aac.00222-24
Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication.
Sett, A., Dubey, V., Bhowmik, S., & Pathania, R. (2024). Decoding Bacterial Persistence: Mechanisms and Strategies for Effective Eradication.. ACS infectious diseases, 10(8), 2525-2539. doi:10.1021/acsinfecdis.4c00270
Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.
Farrington, N., Dubey, V., Johnson, A., Horner, I., Stevenson, A., Unsworth, J., . . . Darlow, C. A. (2024). Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by <i>Pseudomonas aeruginosa</i>.. mBio, 15(2), e0316523. doi:10.1128/mbio.03165-23
2023
Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced <i>Acinetobacter baumannii</i> persisters.
Dubey, V., Gupta, R., & Pathania, R. (2023). Targeting Superoxide dismutase confers enhanced Reactive Oxygen Species mediated eradication of Polymyxin B induced <i>Acinetobacter baumannii</i> persisters.. Antimicrobial agents and chemotherapy, 95(5), AAC.02180-AAC.02120. doi:10.1128/aac.02180-20
2022
Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.
Dubey, V., Devnath, K., Gupta, V. K., Kalyan, G., Singh, M., Kothari, A., . . . Pathania, R. (2022). Disulfiram enhances meropenem activity against NDM- and IMP-producing carbapenem-resistant Acinetobacter baumannii infections.. The Journal of antimicrobial chemotherapy, 77(5), 1313-1323. doi:10.1093/jac/dkac057
2019
Biofilms in Antimicrobial Activity and Drug Resistance
Bhando, T., Dubey, V., & Pathania, R. (2019). Biofilms in Antimicrobial Activity and Drug Resistance. Unknown Journal, 109-139. doi:10.1007/978-981-13-8503-2_6
Computational Prediction of sRNA in Acinetobacter baumannii.
Arya, S., Dubey, V., Sen, D., Sharma, A., & Pathania, R. (2019). Computational Prediction of sRNA in Acinetobacter baumannii.. Methods in molecular biology (Clifton, N.J.), 1946, 307-320. doi:10.1007/978-1-4939-9118-1_27
2018
The unusual glycine-rich C terminus of the <i>Acinetobacter baumannii</i> RNA chaperone Hfq plays an important role in bacterial physiology.
Sharma, A., Dubey, V., Sharma, R., Devnath, K., Gupta, V. K., Akhter, J., . . . Pathania, R. (2018). The unusual glycine-rich C terminus of the <i>Acinetobacter baumannii</i> RNA chaperone Hfq plays an important role in bacterial physiology.. The Journal of biological chemistry, 293(35), 13377-13388. doi:10.1074/jbc.ra118.002921